(11beta)-11,17-Dihydroxy-3,20-dioxopregna-1,4-dien-21-yl 3,3-dimethylbutanoate(CAS: 7681-14-3)

This compound is subject to various regulatory guidelines including GHS classification, REACH regulations, and FDA/EPA requirements. It is essential to comply with local and international regulations for the handling, storage, and disposal of this compound to ensure safety and environmental protection.

In synthesis, alternatives to (11beta)-11,17-Dihydroxy-3,20-dioxopregna-1,4-dien-21-yl 3,3-dimethylbutanoate include using isomers or analogs such as 17α-hydroxyprogesterone. Common alternative reagents include other steroid precursors and synthetic intermediates, which can provide similar functionality.

The market for (11beta)-11,17-Dihydroxy-3,20-dioxopregna-1,4-dien-21-yl 3,3-dimethylbutanoate shows increasing interest in its application in pharmaceuticals and research, particularly in hormone therapy and reproductive health studies. Emerging trends include the exploration of its potential in new drug formulations and personalized medicine.

Waste containing (11beta)-11,17-Dihydroxy-3,20-dioxopregna-1,4-dien-21-yl 3,3-dimethylbutanoate should be collected in suitable containers and stored in a secure, well-ventilated area. For disposal, it is recommended to use professional waste disposal services that comply with local regulations. Environmental precautions include proper incineration or other chemical reduction methods to ensure minimal environmental impact.